DK1824475T3 - Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol - Google Patents

Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol

Info

Publication number: DK1824475T3
Authority: DK; Denmark
Prior art keywords: delta9; tetrahydrocannabinol; trans; purification
Prior art date: 2004-11-22

Application number

DK05807597.9T

Other languages

English (en)

Inventor

Arie L Gutman

Gennady A Nisnevich

Igor Rukhman

Boris Tishin

Marina Etinger

Irina Fedotev

Boris Pertsikov

Ram Khanolkar

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-22

Filing date

2005-11-18

Publication date

2011-06-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35789123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1824475(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-11-18 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2011-06-06 Application granted granted Critical

2011-06-06 Publication of DK1824475T3 publication Critical patent/DK1824475T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Zoology (AREA)
Botany (AREA)
Otolaryngology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

DK05807597.9T 2004-11-22 2005-11-18 Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol DK1824475T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63055604P	2004-11-22	2004-11-22
PCT/EP2005/012378 WO2006053766A1 (en)	2004-11-22	2005-11-18	Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol

Publications (1)

Publication Number	Publication Date
DK1824475T3 true DK1824475T3 (da)	2011-06-06

Family

ID=35789123

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK05807597.9T DK1824475T3 (da)	2004-11-22	2005-11-18	Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK10179360.2T DK2289509T3 (da)	2004-11-22	2005-11-18	Fremgangsmåder til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK10179374.3T DK2356987T3 (da)	2004-11-22	2005-11-18	Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK10179360.2T DK2289509T3 (da)	2004-11-22	2005-11-18	Fremgangsmåder til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK10179374.3T DK2356987T3 (da)	2004-11-22	2005-11-18	Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol

Country Status (30)

Country	Link
US (6)	US8383842B2 (da)
EP (3)	EP1824475B1 (da)
JP (3)	JP4995728B2 (da)
KR (1)	KR100919719B1 (da)
CN (2)	CN102151259A (da)
AR (1)	AR054989A1 (da)
AT (1)	ATE500824T1 (da)
AU (2)	AU2005305944B2 (da)
BR (1)	BRPI0519803A2 (da)
CA (2)	CA2921590C (da)
CY (1)	CY1111471T1 (da)
DE (1)	DE602005026852D1 (da)
DK (3)	DK1824475T3 (da)
EA (1)	EA012299B1 (da)
ES (3)	ES2556802T3 (da)
HR (3)	HRP20110385T1 (da)
HU (2)	HUE025904T2 (da)
IL (1)	IL183306A (da)
ME (2)	ME02306B (da)
MX (1)	MX2007006104A (da)
NO (1)	NO331831B1 (da)
NZ (1)	NZ556038A (da)
PL (3)	PL1824475T3 (da)
PT (2)	PT1824475E (da)
RS (3)	RS54537B1 (da)
SI (3)	SI2289509T1 (da)
TW (2)	TWI369203B (da)
UA (1)	UA88491C2 (da)
WO (1)	WO2006053766A1 (da)
ZA (1)	ZA200706837B (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI369203B (en) *	2004-11-22	2012-08-01	Euro Celtique Sa	Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) *	2005-06-16	2012-06-21	Euro Celtique Sa	Cannabinoid active pharmaceutical ingredient for improved dosage forms
CN101316832A (zh)	2005-09-29	2008-12-03	Amr科技公司	δ-9-四氢大麻酚的生成方法
US8039509B2 (en)	2006-11-10	2011-10-18	Johnson Matthey Public Limited Company	Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
US8980940B2 (en)	2006-11-10	2015-03-17	Johnson Matthey Public Limited Company	Stable cannabinoid compositions and methods for making and storing them
GB0702895D0 (en) *	2007-02-14	2007-03-28	Resolution Chemicals Ltd	Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) *	2007-02-20	2007-03-28	Resolution Chemicals Ltd	Delta 9 - tetrahydrocannabinol processing
WO2009099868A1 (en) *	2008-02-06	2009-08-13	Mallinckrodt Inc.	Process for the preparation of (-) -delta 9-tetrahydrocannabinol
WO2014030053A1 (en)	2012-08-20	2014-02-27	Rhodes Technologies	Systems and methods for increasing stability of dronabinol compositions
EP3160445B1 (en)	2014-06-26	2021-10-20	Island Breeze Systems Ca, LLC	Mdi related products and methods of use
US10207198B2 (en)	2015-01-22	2019-02-19	Phytoplant Research S.L.	Methods of purifying cannabinoids using liquid:liquid chromatography
US11034639B2 (en)	2015-01-22	2021-06-15	Phytoplant Research S.L.	Methods of purifying cannabinoids using liquid:liquid chromatography
US10155708B2 (en) *	2015-01-22	2018-12-18	Phytoplant Research S.L.	Methods of purifying cannabinoids, compositions and kits thereof
CN106268657A (zh) *	2015-05-14	2017-01-04	株式会社大赛璐	光学异构体用分离剂
US20170008869A1 (en) *	2015-07-10	2017-01-12	Noramco, Inc.	Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
WO2017194173A1 (en) *	2016-05-13	2017-11-16	Symrise Ag	Method for purifying cannabinoid compounds
US10499584B2 (en)	2016-05-27	2019-12-10	New West Genetics	Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10399920B2 (en)	2016-06-01	2019-09-03	S&B Pharma, Inc.	Crystalline form of cannabidiol
US10239808B1 (en)	2016-12-07	2019-03-26	Canopy Holdings, LLC	Cannabis extracts
CN106810426B (zh) *	2016-12-29	2020-05-08	暨明医药科技（苏州）有限公司	一种大麻二酚的合成方法
US11213558B2 (en)	2017-05-17	2022-01-04	Orochem Technologies, Inc.	CBX extraction-isolation process
US10189762B1 (en)	2017-07-07	2019-01-29	Orochem Technologies, Inc.	Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
CA3074173A1 (en) *	2017-09-01	2019-03-07	Pureform Global, Inc.	Synthetic cannabidiol compositions and methods of making the same
EP3745884A1 (en)	2018-01-31	2020-12-09	Canopy Holdings, Llc	Hemp powder
WO2019173582A1 (en) *	2018-03-07	2019-09-12	Socati Technologies	Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol
US11192870B2 (en)	2018-03-07	2021-12-07	Socati Technologies—Oregon, Llc	Continuous isolation of cannabidiol and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol
US11851415B2 (en)	2018-03-07	2023-12-26	Cleen Technology Inc.	Continuous isolation of cannabidiol and cannabinoids and conversion of cannabidiol to delta 8-tetrahydrocannabinol and delta 9-tetrahydrocannabinol
WO2020001770A1 (en) *	2018-06-28	2020-01-02	Symrise Ag	Synthesis of (+)-cannabinoids and their therapeutic effects
CA3073093A1 (en)	2018-08-03	2020-02-06	Biomass Oil Separation Solutions, Llc	Processes and apparatus for extraction of substances and enriched extracts from plant material
US11040932B2 (en)	2018-10-10	2021-06-22	Treehouse Biotech, Inc.	Synthesis of cannabigerol
WO2020089424A1 (en)	2018-10-31	2020-05-07	Enantia, S.L.	Solid compositions of cocrystals of cannabinoids
EP3653596A1 (en) *	2018-11-14	2020-05-20	Indena S.p.A.	Continuous flow synthesis of cannabidiol
CN109734554B (zh) *	2019-02-25	2021-11-23	江苏暨明医药科技有限公司	一种反式-薄荷基-2,8-二烯-1-醇的合成工艺
CN111943813B (zh) *	2019-05-17	2023-04-14	上海特化医药科技有限公司	大麻二酚类化合物的制备方法
WO2020248062A1 (en) *	2019-06-11	2020-12-17	Canopy Growth Corporation	Improved methods for cannabinoid isomerization
WO2020248058A1 (en)	2019-06-11	2020-12-17	Canopy Growth Corporation	Improved methods for converting cannabidiol into delta 8-tetrahydrocannabinol
US10799546B1 (en)	2019-07-26	2020-10-13	Biomass Oil Separation Solutions, Llc	Modular, integrated process and apparatus for extracting, refining and remediating active substances from plant material
US11542243B1 (en)	2019-09-26	2023-01-03	FusionFarms, LLC	Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
AU2020370165A1 (en) *	2019-10-21	2022-04-21	Esolate Ltd	Compositions comprising superfine compounds and production thereof
GB2588455B (en) *	2019-10-25	2022-12-21	Gw Res Ltd	Cannabinoid compound
GB2588457B (en) *	2019-10-25	2022-12-21	Gw Res Ltd	Cannabinoid compound
GB2588456B (en) *	2019-10-25	2023-02-01	Gw Res Ltd	Cannabinoid compound
WO2021181420A1 (en)	2020-03-12	2021-09-16	Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860)	Process for the synthesis of cannabidiol and intermediates thereof
US12029718B2 (en)	2021-11-09	2024-07-09	Cct Sciences, Llc	Process for production of essentially pure delta-9-tetrahydrocannabinol
US12195438B2 (en)	2020-12-10	2025-01-14	Kazmira Llc.	Process for removing THC from cannabinoids
CN113336705B (zh) *	2021-08-09	2021-12-10	中国农业科学院农产品加工研究所	一种大麻二酚-2-咪唑-1-甲酸酯及其应用
CA3263937A1 (en)	2022-08-05	2024-02-08	Salud & Semillas, S.L.	SYNTHESIS OF CANNABINOIDS FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FECL3 * 6H2O AS A CATALYST
CN115583933B (zh) *	2022-10-31	2024-02-06	暨明医药科技（苏州）有限公司	一种高纯度四氢大麻素同系物的制备方法
CN115784836A (zh) *	2022-12-08	2023-03-14	南京康立瑞生物科技有限公司	一种高选择性的制备反式-薄荷基-2,8-二烯-1-醇的方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3507885A (en) *	1966-03-25	1970-04-21	Hoffmann La Roche	3-alkyl-6h-dibenzo(b,d)pyrans
CH481911A (de)	1967-05-19	1969-11-30	Theodor Dr Petrzilka	Verfahren zur Herstellung von tricyclischen Verbindungen
US3854480A (en) *	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
US3668224A (en) *	1970-07-02	1972-06-06	Theodor Petrzilka	PROCESS OF PRODUCING 6a, 10a-TRANS-6a,7,8,10a-TETRAHYDRODIBENZO (b,d)-PYRANS
US4025516A (en)	1975-06-23	1977-05-24	The John C. Sheehan Institute For Research, Inc.	Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans
US4381399A (en)	1981-12-21	1983-04-26	Aerojet-General Corporation	Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
US4861598A (en) *	1986-07-18	1989-08-29	Euroceltique, S.A.	Controlled release bases for pharmaceuticals
US4970075A (en) *	1986-07-18	1990-11-13	Euroceltique, S.A.	Controlled release bases for pharmaceuticals
DE4100441A1 (de) *	1991-01-09	1992-07-16	Mack Chem Pharm	Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
US6703418B2 (en) *	1991-02-26	2004-03-09	Unimed Pharmaceuticals, Inc.	Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection
US5389375A (en)	1993-05-21	1995-02-14	University Of Mississippi	Stable suppository formulations effecting bioavailability of Δ9 -thc
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
AU6111796A (en) *	1995-06-12	1997-01-09	G.D. Searle & Co.	Compositions comprising a cyclooxygenase-2 inhibitor and a 5 -lipoxygenase inhibitor
US6017963A (en) *	1995-11-14	2000-01-25	Euro-Celtique, S.A.	Formulation for intranasal administration
US6328992B1 (en) *	1997-03-03	2001-12-11	Lawrence L. Brooke	Cannabinoid patch and method for cannabis transdermal delivery
GB9726916D0 (en) *	1997-12-19	1998-02-18	Danbiosyst Uk	Nasal formulation
US20020039795A1 (en) *	1998-10-26	2002-04-04	Elsohly Et Al	Method of preparing delta-9-tetrahydrocannabinol
US6730519B2 (en)	1998-10-26	2004-05-04	The University Of Mississippi	Method of preparing delta-9-tetrahydrocannabinol
US6509005B1 (en) *	1998-10-27	2003-01-21	Virginia Commonwealth University	Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
FI990915A0 (fi) *	1999-04-23	1999-04-23	Orion Yhtymae Oyj	Jauheinhalaattori
US6403126B1 (en) *	1999-05-26	2002-06-11	Websar Innovations Inc.	Cannabinoid extraction method
US6555139B2 (en) *	1999-06-28	2003-04-29	Wockhardt Europe Limited	Preparation of micron-size pharmaceutical particles by microfluidization
US6747058B1 (en) *	1999-08-20	2004-06-08	Unimed Pharmaceuticals, Inc.	Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US6620351B2 (en) *	2000-05-24	2003-09-16	Auburn University	Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
GB2368061B (en) *	2000-10-20	2005-05-11	Gw Pharmaceuticals Ltd	Dose dispensing apparatus
BR0115382A (pt) *	2000-10-30	2003-09-16	Euro Celtique Sa	Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica
US6730330B2 (en) *	2001-02-14	2004-05-04	Gw Pharma Limited	Pharmaceutical formulations
CH695661A5 (de) *	2001-03-06	2006-07-31	Forsch Hiscia Ver Fuer Krebsfo	Pharmazeutische Zusammensetzung.
EP1409473A2 (en) *	2001-03-07	2004-04-21	Websar Innovations Inc.	CONVERSION OF CBD TO $g(D)?8 -THC AND $g(D)?9 -THC
US20030050334A1 (en) *	2001-04-30	2003-03-13	Murty Ram B.	Process for extraction of Delta-9-Tetrahydrocannabinol and other related cannabinoids and preparation of specific strength marijuana cigarettes
GB0112752D0 (en) *	2001-05-25	2001-07-18	Johnson Matthey Plc	Synthesis of cannabinoids
US20030044458A1 (en)	2001-08-06	2003-03-06	Curtis Wright	Oral dosage form comprising a therapeutic agent and an adverse-effect agent
BR0307330A (pt) *	2002-02-01	2004-12-07	Resolution Chemicals Ltd	Produção do delta-9-tetraidrocanabinol
WO2003070506A1 (fr)	2002-02-21	2003-08-28	Biel Timothee	Dispositif d'entraînement pour vehicules a moteur, notamment avec propulsion hybride
UA79281C2 (en) *	2002-04-03	2007-06-11	Solvay Pharm Bv	Stabilized composition comprising a natural cannabinoid compound and process for the preparation thereof
US6946150B2 (en) *	2002-08-14	2005-09-20	Gw Pharma Limited	Pharmaceutical formulation
GB0222077D0 (en)	2002-09-23	2002-10-30	Gw Pharma Ltd	Methods of preparing cannabinoids from plant material
CN100455576C (zh)	2002-11-12	2009-01-28	马林克罗特公司	大麻素的结晶衍生物及大麻素的纯化方法
US20040229939A1 (en) *	2003-02-14	2004-11-18	Chowdhury Dipak K.	Tetrahydrocannabinol compositions and methods of manufacture and use thereof
AU2004287495A1 (en)	2003-11-05	2005-05-19	Unimed Pharmaceuticals, Inc.	Delta-9- the treatment of multiple sclerosis
GB0329635D0 (en) *	2003-12-23	2004-01-28	Johnson Matthey Plc	Process for purifying trans-tetrahydrocannabinol
EP1773801A1 (de) *	2004-07-19	2007-04-18	Cilag Ltd.	Verfahren zur gewinnung von reinem tetrahydrocannabinol
GB0425445D0 (en) *	2004-11-18	2004-12-22	Smithkline Beecham Corp	Novel compositions
TWI369203B (en) *	2004-11-22	2012-08-01	Euro Celtique Sa	Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) *	2005-06-16	2012-06-21	Euro Celtique Sa	Cannabinoid active pharmaceutical ingredient for improved dosage forms
DK2176208T3 (da)	2007-07-30	2015-04-27	Zynerba Pharmaceuticals Inc	Prodrugs for cannabidiol, sammensætninger indeholdende prodrugs for cannabidiol og fremgangsmåder til anvendelse deraf
US8642645B2 (en) *	2011-05-20	2014-02-04	Brooks Kelly Research, LLC.	Pharmaceutical composition comprising Cannabinoids

2005
- 2005-11-02 TW TW094138437A patent/TWI369203B/zh active
- 2005-11-02 TW TW101115368A patent/TWI436991B/zh active
- 2005-11-18 EP EP05807597A patent/EP1824475B1/en not_active Expired - Lifetime
- 2005-11-18 ES ES10179360.2T patent/ES2556802T3/es not_active Expired - Lifetime
- 2005-11-18 DK DK05807597.9T patent/DK1824475T3/da active
- 2005-11-18 JP JP2007541798A patent/JP4995728B2/ja not_active Expired - Lifetime
- 2005-11-18 EA EA200701123A patent/EA012299B1/ru not_active IP Right Cessation
- 2005-11-18 RS RS20160177A patent/RS54537B1/sr unknown
- 2005-11-18 WO PCT/EP2005/012378 patent/WO2006053766A1/en not_active Ceased
- 2005-11-18 RS RSP20110217 patent/RS51706B/sr unknown
- 2005-11-18 SI SI200532029T patent/SI2289509T1/sl unknown
- 2005-11-18 HU HUE10179360A patent/HUE025904T2/en unknown
- 2005-11-18 EP EP10179374.3A patent/EP2356987B1/en not_active Expired - Lifetime
- 2005-11-18 ME MEP-2015-186A patent/ME02306B/me unknown
- 2005-11-18 CN CN2011100402792A patent/CN102151259A/zh active Pending
- 2005-11-18 US US11/791,415 patent/US8383842B2/en active Active
- 2005-11-18 SI SI200531277T patent/SI1824475T1/sl unknown
- 2005-11-18 CA CA2921590A patent/CA2921590C/en not_active Expired - Lifetime
- 2005-11-18 PT PT05807597T patent/PT1824475E/pt unknown
- 2005-11-18 ES ES10179374.3T patent/ES2566480T3/es not_active Expired - Lifetime
- 2005-11-18 BR BRPI0519803-8A patent/BRPI0519803A2/pt not_active IP Right Cessation
- 2005-11-18 PT PT101793602T patent/PT2289509E/pt unknown
- 2005-11-18 UA UAA200706990A patent/UA88491C2/ru unknown
- 2005-11-18 ES ES05807597T patent/ES2362288T3/es not_active Expired - Lifetime
- 2005-11-18 AT AT05807597T patent/ATE500824T1/de active
- 2005-11-18 ME MEP-2016-55A patent/ME02403B/me unknown
- 2005-11-18 PL PL05807597T patent/PL1824475T3/pl unknown
- 2005-11-18 HR HR20110385T patent/HRP20110385T1/hr unknown
- 2005-11-18 PL PL10179360T patent/PL2289509T3/pl unknown
- 2005-11-18 RS RS20150748A patent/RS54338B1/sr unknown
- 2005-11-18 SI SI200532049T patent/SI2356987T1/sl unknown
- 2005-11-18 AR ARP050104849 patent/AR054989A1/es not_active Application Discontinuation
- 2005-11-18 DE DE602005026852T patent/DE602005026852D1/de not_active Expired - Lifetime
- 2005-11-18 EP EP10179360.2A patent/EP2289509B1/en not_active Expired - Lifetime
- 2005-11-18 CN CN2005800398022A patent/CN101076329B/zh not_active Expired - Lifetime
- 2005-11-18 DK DK10179360.2T patent/DK2289509T3/da active
- 2005-11-18 DK DK10179374.3T patent/DK2356987T3/da active
- 2005-11-18 NZ NZ556038A patent/NZ556038A/en not_active IP Right Cessation
- 2005-11-18 PL PL10179374.3T patent/PL2356987T3/pl unknown
- 2005-11-18 HU HUE10179374A patent/HUE027197T2/en unknown
- 2005-11-18 CA CA2587957A patent/CA2587957C/en not_active Expired - Lifetime
- 2005-11-18 AU AU2005305944A patent/AU2005305944B2/en not_active Ceased
- 2005-11-18 MX MX2007006104A patent/MX2007006104A/es active IP Right Grant
2007
- 2007-05-17 IL IL183306A patent/IL183306A/en active IP Right Grant
- 2007-05-30 ZA ZA2007/06837A patent/ZA200706837B/en unknown
- 2007-06-11 NO NO20072964A patent/NO331831B1/no unknown
- 2007-06-21 KR KR20077014158A patent/KR100919719B1/ko not_active Expired - Fee Related
- 2007-10-18 JP JP2007270825A patent/JP5048448B2/ja not_active Expired - Lifetime
2010
- 2010-01-21 AU AU2010200227A patent/AU2010200227A1/en not_active Abandoned
2011
- 2011-05-17 CY CY20111100473T patent/CY1111471T1/el unknown
2012
- 2012-03-26 JP JP2012068947A patent/JP2012180350A/ja active Pending
2013
- 2013-02-22 US US13/774,955 patent/US8937097B2/en not_active Expired - Lifetime
2015
- 2015-01-13 US US14/596,034 patent/US9278083B2/en not_active Expired - Lifetime
- 2015-11-30 HR HRP20151301TT patent/HRP20151301T1/hr unknown
2016
- 2016-03-04 US US15/061,891 patent/US20160199344A1/en not_active Abandoned
- 2016-03-04 US US15/061,859 patent/US9675581B2/en not_active Expired - Fee Related
- 2016-03-04 US US15/061,780 patent/US9744151B2/en not_active Expired - Fee Related
- 2016-03-23 HR HRP20160300TT patent/HRP20160300T1/hr unknown

Also Published As

Publication number	Publication date
US9675581B2 (en)	2017-06-13
IL183306A (en)	2012-06-28
US8383842B2 (en)	2013-02-26
SI2289509T1 (sl)	2016-01-29
WO2006053766A1 (en)	2006-05-26
BRPI0519803A2 (pt)	2009-03-17
DE602005026852D1 (de)	2011-04-21
CA2587957A1 (en)	2006-05-26
PL2356987T3 (pl)	2016-09-30
PL1824475T3 (pl)	2011-09-30
CA2921590A1 (en)	2006-05-26
NO331831B1 (no)	2012-04-16
NO20072964L (no)	2007-08-17
HUE027197T2 (en)	2016-10-28
HK1154796A1 (en)	2012-05-04
JP4995728B2 (ja)	2012-08-08
WO2006053766A8 (en)	2006-12-14
US9278083B2 (en)	2016-03-08
CY1111471T1 (el)	2015-08-05
RS51706B (sr)	2011-10-31
ES2556802T3 (es)	2016-01-20
KR20070086529A (ko)	2007-08-27
US9744151B2 (en)	2017-08-29
DK2289509T3 (da)	2015-11-23
JP2012180350A (ja)	2012-09-20
PT2289509E (pt)	2015-12-23
DK2356987T3 (da)	2016-03-21
MX2007006104A (es)	2007-07-11
ES2362288T3 (es)	2011-06-30
TWI436991B (zh)	2014-05-11
HRP20110385T1 (hr)	2011-06-30
SI1824475T1 (sl)	2011-06-30
UA88491C2 (ru)	2009-10-26
JP5048448B2 (ja)	2012-10-17
HK1159500A1 (en)	2012-08-03
ME02306B (me)	2016-06-20
PL2289509T3 (pl)	2016-04-29
PT1824475E (pt)	2011-06-01
US20160184261A1 (en)	2016-06-30
HUE025904T2 (en)	2016-05-30
ME02403B (me)	2016-09-20
NZ556038A (en)	2009-12-24
CN101076329A (zh)	2007-11-21
AU2005305944B2 (en)	2010-03-04
JP2008101000A (ja)	2008-05-01
EA012299B1 (ru)	2009-08-28
EP2289509B1 (en)	2015-10-14
KR100919719B1 (ko)	2009-10-06
TWI369203B (en)	2012-08-01
EP2289509A2 (en)	2011-03-02
JP2008520608A (ja)	2008-06-19
TW201302722A (zh)	2013-01-16
SI2356987T1 (sl)	2016-04-29
RS54537B1 (sr)	2016-06-30
ATE500824T1 (de)	2011-03-15
EP2356987A1 (en)	2011-08-17
CN101076329B (zh)	2011-08-10
US20150126596A1 (en)	2015-05-07
EP1824475A1 (en)	2007-08-29
US20160199344A1 (en)	2016-07-14
EP1824475B1 (en)	2011-03-09
HRP20151301T1 (hr)	2016-01-01
EP2289509A3 (en)	2011-08-10
HK1109058A1 (en)	2008-05-30
IL183306A0 (en)	2007-09-20
TW200633695A (en)	2006-10-01
US20160184260A1 (en)	2016-06-30
ES2566480T3 (es)	2016-04-13
AU2010200227A1 (en)	2010-02-11
CA2587957C (en)	2016-05-03
CN102151259A (zh)	2011-08-17
EP2356987B1 (en)	2016-01-06
RS54338B1 (sr)	2016-02-29
AU2005305944A1 (en)	2006-05-26
US20130171259A1 (en)	2013-07-04
HRP20160300T1 (hr)	2016-04-22
ZA200706837B (en)	2008-04-30
US8937097B2 (en)	2015-01-20
US20090298930A1 (en)	2009-12-03
EA200701123A1 (ru)	2007-12-28
AR054989A1 (es)	2007-08-01
CA2921590C (en)	2019-09-24

Publication	Publication Date	Title
DK1824475T3 (da)	2011-06-06	Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
DK1667986T3 (da)	2013-05-06	Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK3121169T3 (da)	2022-02-28	Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
DK1888033T3 (da)	2014-05-26	Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
DK1934179T3 (da)	2010-08-09	Fremgangsmåder og mellemprodukter
DK1644021T3 (da)	2012-10-29	Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK1948852T3 (da)	2019-01-02	Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DE602005012267D1 (de)	2009-02-26	N von geräten
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
DK1647529T3 (da)	2015-12-21	Fremgangsmåde til oprensing af spildevand
DK3321359T3 (da)	2021-03-08	Variante former af uratoxidase og anvendelse deraf
DK1858488T4 (da)	2022-09-12	Tigecyclinsammensætninger og fremgangsmåder til fremstilling deraf
DK3403657T3 (da)	2022-02-28	Anvendelse af oligouronater til behandling af slimhyperviskositet
DE602006004463D1 (de)	2009-02-05	Kristallform von asenapinmaleat
DK1750713T3 (da)	2013-02-11	Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner
DK1896077T3 (da)	2012-12-03	Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
PT1763520E (pt)	2009-03-23	Utilização de benzopiranonas trissubstituídas
DK1745844T3 (da)	2013-06-10	System og fremgangsmåde til bortskaffelse af urenheder
DK1919290T3 (da)	2014-04-22	Fremgangsmåder og produkter til behandling af sygdomme
DK3332789T3 (da)	2022-07-11	Cladribinkur til behandling af multipel sklerose
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1740534T3 (da)	2008-10-27	Fremgangsmåde til rensning af mesotrion